HOME >> MEDICINE >> NEWS
Penn critical-care physicians recommend strategies when facing requests to end supplemental oxygen

Halpern.

Both Halpern and Hansen-Flaschen have received requests from patients to stop their flow of supplemental oxygen, resulting in death. Halpern first grappled with the difficulty of withdrawing oxygen from an awake and alert patient when, as a first year medical resident, he was treating a hospitalized patient suffering from advanced lung disease and cancer. One morning, the patient said he'd "had enough" and tugged on his mask but was too weak to remove it and asked for Halpern's help to do so. Halpern debated this request with the attending physician who was concerned that the patient would experience air hunger and fear after oxygen was removed, necessitating high doses of sedating drugs. He worried this might constitute a form of euthanasia.

Hansen-Flaschen received a similar request from an outpatient who suffered from an advanced lung disease and was living at home. He could no longer get out of bed and his quality of life had seriously deteriorated. The patient wanted to stop his oxygen therapy and asked Hansen-Flaschen to help him avoid a sense of suffocation afterwards. "I had to ask myself, is this participating in a patient's death or is it simply respecting a patient's request? Plus, there's no way to predict an individual's response to removing supplemental oxygen and how much they will suffer."

Hansen-Flaschen notes "Two-thirds of critical care patients in this country are cared for by general physicians or others without special training in critical care." In light of this, Halpern said he hoped that this commentary "will provide a place for physicians to turn when faced with this particular dilemma. We hope that our recommendations may allow physicians to heed requests for the withdrawal of life-sustaining oxygen as readily as they may heed requests for the withdrawal of other life-sustaining therapies, such as mechanical ventilation and dialysis."

The commentary addresses specific concerns physicians may hav
'"/>

Contact: Susanne Hartman
susanne.hartman@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
19-Sep-2006


Page: 1 2 3

Related medicine news :

1. New research finds high prevalence of smoking among physicians in China
2. Personal comments by physicians distract from patient needs
3. Institute of Medicine Advisory: Public health physicians
4. Do financial incentives for physicians improve quality of care for patients?
5. Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
6. Major employers, physicians, stakeholders unite to revolutionize Americas healthcare system
7. Marked departure in Medicare practice of paying physicians in Geriatric Care Improvement Act
8. Research finds that male athletes prefer female team physicians
9. Joint Principles of PC-MH released by organizations representing more than 300,000 physicians
10. Race impacts professional lives of physicians of African descent
11. Study calls for 39 percent more family physicians

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: